Biosimilars

A new era in medicine

Choose to be informed

Sign up for updates

Expanding Access and Awareness

…Biological medicines

Partnership for Biosimilars Education and Access

Whether you are a community leader, health care professional, or part of an organization, there are simple ways you can make a difference.

STATE LAWS AND BIOSIMILARS

Find Out More About the Increasing Number of States Passing Laws Regarding the Substitution of Biosimilars

ADVANCES IN THERAPY

Awareness, Knowledge and Perceptions of Biosimilars among Specialty Physicians

SIGNIFICANT HEALTHCARE SAVINGS POSSIBLE IF U.S. CULTIVATES A ROBUST BIOSIMILARS MARKET

New Biosimilars Forum and Medicines for Europe research details how the EU created a competitive, multisource biosimilars market that increases patient access, creates cost-savings

THE BASIC FACTS ABOUT BIOSIMILARS

Find Out More About the Basic Science Around Biosimilars

HCP SURVEY

Read our survey that analyzes the knowledge, awareness and perception of biosimilars among specialty physcians in the U.S.

STAY CONNECTED

Get information and updates from the Biosimilars Forum

EDUCATIONAL RESOURCES

Check out our downloadable resources

5 MAJOR KNOWLEDGE GAPS IDENTIFIED

  • Defining biosimilars & biosimilarity
  • Understanding extrapolation
  • Understanding the pathway
  • Appreciating the similar safety of biosimilars and their reference products
  • Understanding interchangability

SURVEY IDENTIFIES FIVE MAJOR KNOWLEDGE GAPS IN BIOSIMILARS

The Biosimilars Forum conducted a survey of 1,201 U.S. specialty physicians and determined there are notable gaps in their knowledge about biosimilar concepts. The survey questioned physicians who are high prescribers of biologics, including:

  • Dermatologists
  • Gastroenterologists
  • Hematologist-oncologists
  • Medical oncologists
  • Nephrologists
  • Rheumatologists

The survey results were published in the journal, Advances in Therapy.